LifePlan Financial’s Gilead Sciences GILD Stock Holding History

LifePlan Financial’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$682K	Buy	5,399 +265	+5%	+$34.9K	0.48%	60
2026 Q1	$716K	Buy	5,134 +295	+6%	+$41.3K	0.53%	63
2025 Q4	$594K	Sell	4,839 -657	-12%	-$79.8K	0.46%	64
2025 Q3	$610K	Sell	5,496 -131	-2%	-$14.9K	0.48%	61
2025 Q2	$624K	Sell	5,627 -1,228	-18%	-$131K	0.52%	55
2025 Q1	$768K	Buy	6,855 +868	+14%	+$89.6K	0.67%	45
2024 Q4	$553K	Buy	5,987 +504	+9%	+$45.4K	0.49%	58
2024 Q3	$460K	Sell	5,483 -890	-14%	-$67.9K	0.39%	67
2024 Q2	$437K	Sell	6,373 -402	-6%	-$26.8K	0.4%	62
2024 Q1	$496K	Buy	6,775 +4,223	+165%	+$325K	0.45%	61
2023 Q4	$207K	Buy	+2,552	New	+$199K	0.21%	88

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

LifePlan Financial's GILD Position: Q2 2026 in Review

LifePlan Financial increased its Gilead Sciences (GILD) stake by 5.2% in Q2 2026, buying an estimated $34.9K and bringing the position to 5,399 shares worth $682K. The position accounts for 0.48% of the portfolio, ranked #60.

LifePlan Financial first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $768K in Q1 2025. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

LifePlan Financial held 5,399 shares of Gilead Sciences worth $682K as of Q2 2026.
LifePlan Financial bought 265 Gilead Sciences shares in Q2 2026, an estimated $34.9K.
Gilead Sciences made up 0.48% of LifePlan Financial's portfolio in Q2 2026, its #60 holding.
LifePlan Financial first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
LifePlan Financial's Gilead Sciences position peaked at $768K in Q1 2025.
1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on LifePlan Financial's 13F filing for Q2 2026, filed 21 Jul 2026.